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Abstract
Breast cancer is the most common cancer in women in Germany. In addition to physical examinations (palpation) 
mammographies are offered every two years to women aged 50 to 69 years as part of the mammography screening 
programme. For this purpose women are invited in writing and recive a leaflet with information about the background, 
aims procedures, benefits and possible disadvantages that the screening programme might have. The invitation 
and the leaflet were revised in 2015 to better support the invited women in making an informed decision about 
whether they should participate in the programme. In the GEDA 2014/2015-EHIS study, the respondents provided 
the date of their last mammography and the reason for this. A mammography has been performed on 74.2% of 
women aged 50 to 69 years within the last two years. 80.7% of these women stated that the reason for this was an 
invitation sent out by the national screening programme.
  BREAST CANCER · MAMMOGRAPHY · CANCER SCREENING · HEALTH MONITORING · GERMANY
Introduction
Breast cancer is the most common cancer in women in 
Germany. One in eight women suffers from breast can-
cer at some point, with the mean age of onset being 64 
[1]. Breast cancer screening aims to identify breast cancer 
as early as possible so as to provide a milder and better 
form of treatment, and, in turn, improve the quality of 
life of breast cancer patients and their chances of recov-
ery. However, screening cannot prevent the development 
of breast cancer, and the procedures used to test for the 
condition may also come with disadvantages and risks.
From the age of 30, women with German statutory 
health insurance are entitled to an annual breast cancer 
examination (palpation of the breasts and an examina-
tion of the regional lymph nodes) by a gynaecologist. 
The aim of this examination is to detect palpable changes 
(nodes) that should clarified diagnostically by imaging 
techniques such as mammography or ultrasound and, 
if necessary, by a biopsy. Alongside this examination, 
women aged 50 to 69 years can have an X-ray of the 
breast (a mammography) conducted every two years as 
part of the breast cancer screening programme [2]. The 
women of this age group are invited to the screening 
programme on the basis of data from the Residents' 
Registration Office in writing. A leaflet is also sent out 
at the same time which provides information about the 
background, goals, content and the procedure itself as 
well as any benefits and possible disadvantages that the 
screening programme might have. The programme is 
aimed at detecting and treating breast cancer as early 
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breast cancer mortality in woman aged 50 to 69 years 
has been falling, mainly due to advances in therapy [3]. 
The extent to which the mammography screening pro-
gramme can further reduce breast cancer mortality is 
not yet predictable due to its short duration.
Indicator
The GEDA 2014/2015-EHIS study collected data on the 
utilization of the latest mammography using a self-ad-
ministered questionnaire which the respondents com-
pleted on paper or online. It included the question, 
‘When was the last time you had a mammography?’ The 
following answers were accepted: ‘Within the past 12 
months’, ‘1 to less than 2 years ago’, ‘2 to less than 3 
years, ‘3 years or more’ and ‘never’. This was followed 
by the question: ‘What was the reason the last mam-
mography were performed?’ The following answers were 
accepted: ‘Due to an invitation from the national screen-
ing programme’ and ‘Other reasons, such as referral by 
a gynaecologist’.
This Fact sheet evaluates the utilization of the latest 
mammography (performed within the last two years) for 
women aged 50 to 69 years. The response categories 
‘Within the last 12 months’ and ‘Between 1 and less than 
2 years ago’ were grouped to the category ‘Within the last 
two years’ because women aged 50 to 69 years are invited 
every two years to take part in the screening programme 
for mammography [2]. This allows assessing whether the 
last mammography was performed within the recom-
mended examination interval. In order to see whether 
the mammography was performed as part of the national 
screening programme or for other reasons (see above), 
as possible and reducing the mortality rate of breast can-
cer at the population level. One disadvantage of the 
mammography screening programme is the possibility 
of overdiagnosis. Overdiagnosis refers to the discovery 
of tumours that would have either been identified at a 
later date, or that would have remained undetected and 
would have caused no negative impact on the person’s 
quality of life.
Mammographies are also performed outside the 
screening programme. There are medical reasons for 
examination, e.g. due to a conspicuous palpation. In addi-
tion, opportunistic screenings are also conducted. These 
are conducted when a doctor recommends a mammog-
raphy, because of the presence of another illness or an 
increased risk of breast cancer in the family. No system-
atic invitations or quality assurance exist in these cases.
In 2013, 71,640 women were newly diagnosed with 
breast cancer and 17,853 women died from it [3]. From 
2005 onwards, there was an increase in disease rates 
due to the introduction of the mammography screening 
programme (and the discovery of tumours that would 
otherwise have been diagnosed later without screening 
programme). This has been declining since 2009. In 
addition, the number of detected breast cancer cases at 
an advanced stage is also declining. In the group of 
women aged 50 to 69 years more breast cancer cases in 
their early stages are discovered, which are better to treat 
and have better chance of recovery. This is one indica-
tion that the screening programme is being successful. 
The main goal of the mammography screening pro-
gramme is to reduce breast cancer mortality. Since the 
mid-1990s, i.e. before the programme was introduced, 
GEDA 2014/2015-EHIS
Data holder: Robert Koch Institute
Aims: To provide reliable informa tion 
about the population’s health status, 
health-related behaviour and health care  
in Germany, with the possibility of a  
European comparison 
Method: Questionnaires completed on 
paper or online
Population: People aged 18 years and above 
with permanent residency in Germany
Sampling: Registry office sample; randomly 
selected individuals from 301 communities 
in Germany were invited to participate
Participants: 24,016 people (13,144 women; 
10,872 men)
Response rate: 26.9%
Study period: November 2014 - July 2015
Data protection: This study was undertaken 
in strict accordance with the data protection 
regulations set out in the German Federal 
Data Protection Act and was approved by 
the German Federal Commissioner for Data 
Protection and Freedom of Information.  
Participation in the study was voluntary. 
The participants were fully informed about 
the study’s aims and content and about 
data protection. All participants provided 
written informed consent.
 
More information in German is available at 
www.geda-studie.de
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raphy in terms of education. Nevertheless, women with 
medium level of education were more likely to have had 
more frequent a mammography in the last two years 
than women with low or high level of education.
The majority of women who have had a mammogra-
phy within the last two years (80.7%) indicated that was 
undertaken due to an invitation sent out by the national 
screening programme (Table 2). In the group of women 
aged 50 to 54 years, this reason is given less frequently 
than in other age groups. In fact, almost a quarter of 
women aged 50 to 54 years stated that their last mam-
mography had been conducted for ‘Other reasons’.
A fundamental limitation of the question used in 
GEDA 2014/2015-EHIS is that the study only asked 
the reason for this examination was also assessed. The 
results are stratified according to age and educational 
level. A statistically significant difference between groups 
is assumed if confidence intervals do not overlap.
The analyses are based on data from women aged 
50 to 69 years with valid data at the time of the latest 
mammography (n=4,301). The reason for the last mam-
mography is shown for women who have had a mam-
mogram within the last two years (n=3,143). All calcula-
tions were carried out using a weighting factor that 
corrects for deviations within the sample from the Ger-
man population (as of 31 December 2014) with regard 
to age, district type and level of education. The district 
type reflects the degree of urbanisation and accounts for 
the regional distribution in Germany. The International 
Standard Classification of Education (ISCED) was used 
to classify the participants’ educational and occupational 
qualifications [4]. A detailed description of the method-
ology of GEDA 2014/2015-EHIS can be found in Lange 
et al. 2017 [5] as well as in the article German Health 
Update: New data for Germany and Europe in issue 
1/2017 of the Journal of Health Monitoring.
Results and discussion
According to GEDA 2014/2015-EHIS data, 74.2% of wom-
en aged 50 to 69 years report that they have had a mam-
mogram within the last two years (Table 1). This propor-
tion is smaller in the group of 50- to 54-year-olds than 
in the higher age groups. Other studies have shown that 
the use of (cancer) screening varies according to level 
of educational [6]. Within the individual age groups there 
are no significant differences in utilization of mammog-
74.2% of women aged  
50 to 69 years have under-
gone a mammography  
in the last two years. Women % (95% CI)
Women (total) 74.2 (72.4-76.0)
50-54 Years 68.5 (65.5-71.4)
Low education 67.7 (59.7-74.8)
Medium education  69.6 (65.7-73.2)
High education 66.1 (61.0-70.8)
55-59 Years 77.4 (74.3-80.3)
Low education 75.1 (66.9-81.9)
Medium education  79.4 (75.0-83.2)
High education 72.9 (67.2-78.0)
60-64 Years 77.8 (74.5-80.8)
Low education 73.3 (65.8-79.6)
Medium education  80.3 (76.1-83.9)
High education 74.8 (68.0-80.7)
65-69 Years 75.1 (71.3-78.5)
Low education 72.7 (65.2-79.1)
Medium education  76.4 (71.2-80.9)
High education 73.8 (66.0-80.3)
CI=confidence interval
Table 1 
 The utilization of the latest mammography 
within the last two years, irrespective of the 
reason for the examination among women 
aged 50 to 69 years according to age and 
educational level (n=4,301) 
Source: GEDA 2014/2015-EHIS
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evaluation of the mammography screening programme 
implemented by the Kooperationsgemeinschaft Mam-
mographie (German Mammography Cooperation Asso-
ciation).
Compared to data from DEGS1, the utilization of 
mammography has not increased significantly. For 
DEGS1, 71.3% of women aged 50 to 69 years reported 
that they had had a mammography within the last two 
years [7]; older women slightly more frequently than 
younger women. In DEGS1, the reason for the last mam-
mography was also asked, but it was possible to specify 
several reasons (multiple answers). 65.4% of women 
aged 50 to 69 years who had had a mammography per-
women why they had undertaken their latest mammog-
raphy. As such, it is unclear whether women who 
answered with ‘Other reasons’ had already participated 
in the screening programme earlier, but have since 
undergone another mammography outside the screen-
ing, for example to clarify a conspicuous palpation. 
Therefore, although the GEDA 2014/2015-EHIS data sug-
gests that the mammography screening programme 
reaches many women, mammographies outside the pro-
gramme remains important.
These results can be classified using data from the 
German Health Interview and Examination Survey for 
Adults (DEGS1, 2008-2011) and the results of the annual 
Women aged 50 to 54 years 
report less frequently than 
older women that they have 
undergone a mammography 
in the last two years.
Table 2 
The reason for the latest mammography 
within the last two years among women 
aged 50 to 69 years according to age and 
educational level (n=3,143) 
Source: GEDA 2014/2015-EHIS
Invitation by the national screening programme Other reasons 
Women % (95% CI) % (95% CI)
Women (total) 80.7 (79.0-82.4) 19.3 (17.6-21.0)
50-54 Years 77.5 (74.3-80.5) 22.5 (19.5-25.7)
Low education 83.5 (75.4-89.3) 16.5 (10.7-24.6)
Medium education 76.9 (72.6-80.8) 23.1 (19.2-27.4)
High education 74.5 (68.7-79.6) 25.5 (20.4-31.3)
55-59 Years 84.6 (81.5-87.3) 15.4 (12.7-18.5)
Low education 82.2 (73.2-88.6) 17.8 (11.4-26.8)
Medium education 87.0 (83.1-90.0) 13.0 (10.0-16.9)
High education 78.2 (72.2-83.2) 21.8 (16.8-27.8)
60-64 Years 80.3 (76.7-83.4) 19.7 (16.6-23.3)
Low education 82.0 (73.0-88.4) 18.0 (11.6-27.0)
Medium education 82.5 (77.7-86.4) 17.5 (13.6-22.3)
High education 70.1 (61.6-77.4) 29.9 (22.6-38.4)
65-69 Years 80.8 (77.0-84.2) 19.2 (15.8-23.0)
Low education 75.5 (66.3-82.9) 24.5 (17.1-33.7)
Medium education 84.1 (79.0-88.2) 15.9 (11.8-21.0)
High education 76.6 (67.7-83.6) 23.4 (16.4-32.3)
CI=confidence interval
i
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As with all screening tests, mammography for early 
detection of cancer can be associated not only with 
advantages but also with disadvantages. Overdiagnosis 
or false positives (suspected cases that lead to a nega-
tive result during a follow-up) mean that screening can 
cause unnecessary stress and needless diagnostic pro-
cedures. It can therefore be difficult for women who are 
invited to screenings to understand the personal bene-
fits of mammography screening. In July 2015, the Federal 
Joint Committee adopted an amendment of the cancer 
screening guidelines, which included changing the invi-
tation letter and the leaflet to better assist women in 
making an informed decision about participating in the 
mammography screening programme. The changes 
have been in force since 2016.
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